HALEON PLC LS 0,01
WKN A3DNZQ | ISIN GB00BMX86B70 | Aktie
Aktuelle Entwicklung
Basisinformationen
| Eröffnung | 3,9920 |
| Schluss 16.07.24 | 3,9920 |
| Tagestief | 3,9910 |
| Tageshoch | 3,9920 |
| Vol. (EUR) | - |
| Vol. Stk. | - |
| Preisfeststellung | 11 |
Marktnachrichten
Performance
| Zeitraum | HALEON LS |
|---|---|
| 1 Monat | +2,54 % |
| 1 Jahr | +8,04 % |
| 3 Jahre | - |
| 5 Jahre | - |
52W Hoch (12.07.24):
4,0700 EUR
4,0700 EUR
52W Tief (22.12.23):
3,6250 EUR
3,6250 EUR
Handelsplätze
| Name | Aktuell | Zeit | Vol. Stk. |
|---|---|---|---|
| Xetra | 3,99 EUR | 13:23 | 5,27 Tsd. |
| TradeGate | 3,99 EUR | 13:46 | 1,80 Tsd. |
| Nasdaq Other OTC | 4,27 USD | 16.07.24 | 873 |
| Berlin | 3,96 EUR | 08:08 | 0 |
| Düsseldorf | 3,98 EUR | 12:31 | 0 |
Letzte Umsätze
| Zeit | Vol. Stk. | Kurs |
|---|---|---|
| 13:43:14 | 0 | 3,9910 |
| 13:13:30 | 0 | 3,9910 |
| 12:43:58 | 0 | 3,9910 |
| 12:13:04 | 0 | 3,9910 |
| 11:43:14 | 0 | 3,9910 |
Enthalten in Fonds
| Name | Rücknahmepreis | Perf. 1J | Anteil |
|---|---|---|---|
| Fidelity Funds - Sustainable Europe Equity Fund A-Euro | 28,44 EUR | +16,38 % | 3,43 % |
| MSIF International Resilience Fund I USD | 37,88 USD | +6,61 % | 3,26 % |
| Wellington Strategic Eu.Eq.Fd.D EUR | 30,19 EUR | +21,84 % | 2,83 % |
| UBS (Lux) Key Selection SICAV - Turnaround Equity Opportunities (USD), Anteilsklasse P-acc, USD | 124,67 USD | +7,11 % | 2,68 % |
| UBS(L)Eq.S.Eur.Inc.O.S.(EUR)P a.EUR | 114,61 EUR | +13,95 % | 2,37 % |
Fundamentaldaten
Geschäftsjahresende: 31.12.| Zeitraum | 2023/24 | 2023 | 2022 |
|---|---|---|---|
| Gewinn pro Aktie | - | 0,11 | 0,12 |
| Dividende pro Aktie | - | 0,00 | 0,02 |
| KGV | 29,27 | 28,43 | 28,50 |
| KBV | 1,85 | 1,80 | 1,85 |
| Marktkapitalisierung Mrd. | 30,70 | 29,83 | 30,21 |
Firmenprofil
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. It provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum.
Firmenprofil im DetailNotizen
Loggen Sie sich in Ihren Markets plus Account ein um schnell und einfach persönliche Notizen zu Wertpapiere zu erfassen.